Published in J Immunol on March 01, 2000
Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol (2013) 3.38
Formation and function of the lytic NK-cell immunological synapse. Nat Rev Immunol (2008) 3.17
Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest (2002) 1.83
Src family kinases mediate neutrophil adhesion to adherent platelets. Blood (2006) 1.16
Retracted Functional activation of proline-rich tyrosine kinase2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. BMC Musculoskelet Disord (2009) 1.07
Cell biological steps and checkpoints in accessing NK cell cytotoxicity. Immunol Cell Biol (2014) 1.07
Src-family kinases mediate an outside-in signal necessary for beta2 integrins to achieve full activation and sustain firm adhesion of polymorphonuclear leucocytes tethered on E-selectin. Biochem J (2006) 1.05
β2 integrin induces TCRζ-Syk-phospholipase C-γ phosphorylation and paxillin-dependent granule polarization in human NK cells. J Immunol (2011) 1.02
SRC-dependent outside-in signalling is a key step in the process of autoregulation of beta2 integrins in polymorphonuclear cells. Biochem J (2004) 0.93
Key role of proline-rich tyrosine kinase 2 in interleukin-8 (CXCL8/IL-8)-mediated human neutrophil chemotaxis. Immunology (2004) 0.92
Dibutyltin activates MAP kinases in human natural killer cells, in vitro. Cell Biol Toxicol (2010) 0.88
Candida albicans expresses a focal adhesion kinase-like protein that undergoes increased tyrosine phosphorylation upon yeast cell adhesion to vitronectin and the EA.hy 926 human endothelial cell line. Infect Immun (2002) 0.87
Kinome analysis of receptor-induced phosphorylation in human natural killer cells. PLoS One (2012) 0.87
A signaling network stimulated by β2 integrin promotes the polarization of lytic granules in cytotoxic cells. Sci Signal (2014) 0.87
Functions of the FAK family kinases in T cells: beyond actin cytoskeletal rearrangement. Immunol Res (2014) 0.82
Activation of p44/42 in human natural killer cells decreases cell-surface protein expression: Relationship to tributyltin-induced alterations of protein expression. Toxicol Mech Methods (2010) 0.78
Ziram activates mitogen-activated protein kinases and decreases cytolytic protein levels in human natural killer cells. Toxicol Mech Methods (2011) 0.77
Origins of the cytolytic synapse. Nat Rev Immunol (2016) 0.75
The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell (1996) 3.82
Natural killer cells: characteristics and regulation of activity. Immunol Rev (1979) 3.14
The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol Today (1994) 2.66
Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med (1994) 2.47
Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J (2000) 2.41
The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol (1998) 2.32
Involvement of p21ras activation in T cell CD69 expression. Eur J Immunol (1994) 1.85
Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization. Ann Oncol (2010) 1.81
Calcium modulation activates Epstein-Barr virus genome in latently infected cells. Science (1986) 1.61
Expression pattern of notch1, 2 and 3 and Jagged1 and 2 in lymphoid and stromal thymus components: distinct ligand-receptor interactions in intrathymic T cell development. Int Immunol (1999) 1.60
Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med (1994) 1.55
Video laparoscopic surgery: is out-of-hospital thromboprophylaxis necessary? J Thromb Haemost (2005) 1.45
The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood (1998) 1.42
Vitamin D3: a transcriptional modulator of the interferon-gamma gene. Eur J Immunol (1998) 1.39
From Erasmus to Socrates: should mobility move from students to teachers? Lancet (1996) 1.39
Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci Lett (1992) 1.38
Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation. J Clin Invest (1996) 1.36
Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients. Am J Med Genet B Neuropsychiatr Genet (2007) 1.35
The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Clin Cancer Res (2001) 1.33
Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J Cell Physiol (1990) 1.32
Integrin-mediated adhesion and signaling in tumorigenesis. Biochim Biophys Acta (1994) 1.30
Rapid in vivo assay of mouse natural killer cell activity. J Natl Cancer Inst (1979) 1.26
Reactivity of anti-asialo GM1 serum with tumoricidal and non-tumoricidal mouse macrophages. J Leukoc Biol (1985) 1.23
Steroid sensitivity of thymocyte subpopulations during intrathymic differentiation. Effects of 17 beta-estradiol and dexamethasone on subsets expressing T cell antigen receptor or IL-2 receptor. J Immunol (1989) 1.23
Continuous in vivo activation and transient hyporesponsiveness to TcR/CD3 triggering of human gut lamina propria lymphocytes. Eur J Immunol (1993) 1.22
bcl-2 over-expression enhances NF-kappaB activity and induces mmp-9 transcription in human MCF7(ADR) breast-cancer cells. Int J Cancer (2000) 1.22
The BFRF1 gene of Epstein-Barr virus encodes a novel protein. J Virol (2000) 1.20
Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol (2003) 1.20
Cytotoxic effector cells with the characteristics of natural killer cells in the lungs of mice. Int J Cancer (1980) 1.20
Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. Eur J Neurosci (2000) 1.18
Identification of the CC chemokines TARC and macrophage inflammatory protein-1 beta as novel functional ligands for the CCR8 receptor. Eur J Immunol (1998) 1.18
Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment. Oncogene (2007) 1.17
In vivo natural reactivity of mice against tumor cells. Int J Cancer (1980) 1.16
Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity. J Immunol (1988) 1.15
Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J Exp Med (1992) 1.14
Increase of mouse resistance to Candida albicans infection by thymosin alpha 1. Infect Immun (1982) 1.13
Localization of Epstein-Barr virus envelope glycoproteins on the inner nuclear membrane of virus-producing cells. J Virol (1989) 1.11
Lymphokine-activated tumor inhibition in vivo. I. The local administration of interleukin 2 triggers nonreactive lymphocytes from tumor-bearing mice to inhibit tumor growth. J Immunol (1985) 1.11
Expression of trKB neurotrophin receptor during T cell development. Role of brain derived neurotrophic factor in immature thymocyte survival. J Immunol (1996) 1.09
p140Cap dual regulation of E-cadherin/EGFR cross-talk and Ras signalling in tumour cell scatter and proliferation. Oncogene (2010) 1.09
Laparoscopic adhesiolysis: consensus conference guidelines. Colorectal Dis (2012) 1.08
A comprehensive overview of grain development in Brachypodium distachyon variety Bd21. J Exp Bot (2011) 1.08
Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice. J Exp Med (1996) 1.08
Detection of melanoma cells in sentinel lymph nodes by reverse transcriptase-polymerase chain reaction: prognostic significance. Ann Surg Oncol (2004) 1.07
Interleukin 2 activated tumor inhibition in vivo depends on the systemic involvement of host immunoreactivity. J Immunol (1987) 1.07
Human herpesvirus 6 infection in neoplastic and normal brain tissue. J Med Virol (2001) 1.06
In vivo reactivity of mouse natural killer (NK) cells against normal bone marrow cells. Cell Immunol (1981) 1.06
Ubiquitination and degradation of Syk and ZAP-70 protein tyrosine kinases in human NK cells upon CD16 engagement. Proc Natl Acad Sci U S A (2001) 1.05
Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins. Cancer Res (1995) 1.05
Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis. Ann Oncol (2012) 1.05
Human natural killer cells express VLA-4 and VLA-5, which mediate their adhesion to fibronectin. J Immunol (1991) 1.05
Identification and characterization of the product encoded by ORF69 of Kaposi's sarcoma-associated herpesvirus. J Virol (2008) 1.04
Gastric pathology in patients with common variable immunodeficiency. Gut (1999) 1.04
Laparoscopic ventral incisional hernia repair: evidence-based guidelines of the first Italian Consensus Conference. Hernia (2013) 1.03
Human B-cell immune response to the polymorphic epithelial mucin. Cancer Res (1993) 1.03
Syk-dependent phosphorylation of Shc. A potential link between FcepsilonRI and the Ras/mitogen-activated protein kinase signaling pathway through SOS and Grb2. J Biol Chem (1996) 1.02
RAC1/P38 MAPK signaling pathway controls beta1 integrin-induced interleukin-8 production in human natural killer cells. Immunity (2000) 1.02
Selective binding of the epidermal growth factor and its specific effects on the epithelial cells of the cornea. Exp Eye Res (1972) 1.02
Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2. Leukemia (2012) 1.02
Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. Role of steroid receptor and antigen-responsive 5'-flanking sequences. J Biol Chem (1990) 1.02
I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. Blood (2000) 1.01
Immunoreactivity for IL-1 beta and TNF alpha in human lymphoid and nonlymphoid tissues. Am J Pathol (1989) 1.01
CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum. J Neuroimmunol (1998) 1.01
Integrin-mediated ras-extracellular regulated kinase (ERK) signaling regulates interferon gamma production in human natural killer cells. J Exp Med (1998) 1.00
Acute myocardial infarction during treatment with intravenous immunoglobulin for idiopathic thrombocytopenic purpura (ITP) Am J Hematol (2000) 1.00
Transfer to cyclophosphamide-treated mice of natural killer (NK) cells and in vivo natural reactivity against tumors. J Immunol (1981) 1.00
Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma. J Pathol (2001) 1.00
Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif. Mol Cell Biol (1991) 0.99
SDF-1alpha-mediated modulation of synaptic transmission in rat cerebellum. Eur J Neurosci (2000) 0.99
Role for the Rac1 exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity. J Immunol (1999) 0.98
Intracellular transport and maturation pathway of human herpesvirus 6. Virology (1999) 0.98
Proline-rich tyrosine kinase-2 activation by beta 1 integrin fibronectin receptor cross-linking and association with paxillin in human natural killer cells. J Immunol (1997) 0.98
Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b. Oncogene (2009) 0.98
Role of the alpha 5 beta 1 integrin receptor in the proliferative response of quiescent human melanoma cells to fibronectin. Cancer Res (1992) 0.98
Up-modulation of the expression of functional keratinocyte growth factor receptors induced by high cell density in the human keratinocyte HaCaT cell line. Cell Growth Differ (2000) 0.98